Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

CYTOCHROME P450 INHIBITION USING RECOMBINANT PROTEINS AND MASS SPECTROMETRY/MULTIPLE REACTION MONITORING TECHNOLOGY IN A CASSETTE INCUBATION

Richard Weaver, Ken S. Graham, Iain G. Beattie and Rob J. Riley
Drug Metabolism and Disposition July 2003, 31 (7) 955-966; DOI: https://doi.org/10.1124/dmd.31.7.955
Richard Weaver
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken S. Graham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iain G. Beattie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rob J. Riley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 31 no. 7 955-966
DOI 
https://doi.org/10.1124/dmd.31.7.955
PubMed 
12814974

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received November 25, 2002
  • Accepted March 24, 2003
  • Published online July 1, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Richard Weaver,
  2. Ken S. Graham,
  3. Iain G. Beattie and
  4. Rob J. Riley
  1. Physical & Metabolic Science, AstraZeneca R&D Charnwood, Loughborough, United Kingdom
  1. Address correspondence to:
    Dr. Richard Weaver, Physical & Metabolic Science, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough UK LE11 5RH. E-mail: richard.weaver1{at}astrazeneca.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 201703012
Sep 201702413
Oct 201712213
Nov 201724715
Dec 20171189
Jan 20180168
Feb 201831914
Mar 201831221
Apr 201812821
May 20180216
Jun 201822310
Jul 201811510
Aug 201841613
Sep 20180127
Oct 201801510
Nov 201811826
Dec 20181754
Jan 20191935
Feb 2019911
Mar 20192221
Apr 20191512
May 2019900
Jun 20191319
Jul 20191810
Aug 20191832
Oct 20192753
Nov 20192224
Dec 20192371
Jan 20202531
Feb 20201611
Mar 20201144
May 20202311
Jun 20202100
Jul 20201200
Aug 2020201
Sep 20201630
Oct 20202401
Nov 20201821
Dec 20201401
Jan 202121152
Feb 202127185
Mar 20213423
Apr 20212634
May 20212260
Jun 20211760
Jul 20211560
Aug 20213253
Sep 20211353
Oct 20212031
Nov 20212111
Dec 20212550
Jan 20222211
Feb 20221820
Mar 20221921
Apr 20221690
May 20222941
Jun 20223621
Jul 20222543
Aug 20222632
Sep 20223121
Oct 202216112
Nov 20223741
Dec 20221931
Jan 20235341
Feb 20233031
Mar 20233912

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 31 (7)
Drug Metabolism and Disposition
Vol. 31, Issue 7
1 Jul 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
CYTOCHROME P450 INHIBITION USING RECOMBINANT PROTEINS AND MASS SPECTROMETRY/MULTIPLE REACTION MONITORING TECHNOLOGY IN A CASSETTE INCUBATION
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

CYTOCHROME P450 INHIBITION USING RECOMBINANT PROTEINS AND MASS SPECTROMETRY/MULTIPLE REACTION MONITORING TECHNOLOGY IN A CASSETTE INCUBATION

Richard Weaver, Ken S. Graham, Iain G. Beattie and Rob J. Riley
Drug Metabolism and Disposition July 1, 2003, 31 (7) 955-966; DOI: https://doi.org/10.1124/dmd.31.7.955

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

CYTOCHROME P450 INHIBITION USING RECOMBINANT PROTEINS AND MASS SPECTROMETRY/MULTIPLE REACTION MONITORING TECHNOLOGY IN A CASSETTE INCUBATION

Richard Weaver, Ken S. Graham, Iain G. Beattie and Rob J. Riley
Drug Metabolism and Disposition July 1, 2003, 31 (7) 955-966; DOI: https://doi.org/10.1124/dmd.31.7.955
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
  • Absorption, Metabolism, and Excretion of Taselisib
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics